Zydus Cadila News
New cases were confirmed Saturday in Germany and Italy, with Belgium, Israel and Hong Kong also reporting that the variant has been found in travellers
The three doses of ZyCoV-D are to be administered 28 days apart. The vaccine was given emergency use authorisation (EUA) by the Indian drug regulator on 20 August
The Ahmedabad-based pharma company earlier had proposed a price of Rs 1,900 for its three-dose regimen, sources said.
Representatives from seven vaccine makers — Serum Institute of India, Bharat Biotech, Dr Reddy's Laboratories, Zydus Cadila, Biological E, Gennova Biopharma and Panacea Biotech — participated in the meeting
Centre will decide on vaccination of children, adolescents on ‘scientific rationale’, says COVID Task Force chief
Zydus Cadila’s needle-free vaccine ZyCoV-D is set to become the first vaccine that will be available in India for those in the age group of 12-18 years
Children will be given half the proportion of what adults get ie, a dose of 0.5 ml will be given to kids compared to 1ml in adults. It will be an intramuscular injection like other vaccines
Conversation between Zydus Cadila, Centre underway on pricing for first DNA-based needle-free COVID-19 vaccine
The pharma company is learnt to have proposed ₹1,900 for its three-dose jab that can be given to those above 12 years of age.
The government had said that the indigenously-developed, world's first DNA-based needle-free COVID-19 vaccine by Zydus Cadila will be introduced in the nationwide anti-coronavirus vaccination drive shortly.
While the market for these drugs may not be huge at present due to a drop in COVID-19 cases and extended timelines, experts believe that these drugs will help control future waves and protect people with weak immunity
The government is aiming to roll out India’s first approved vaccine for kids aged 12 years and above on 2 October, the birthday of Mahatma Gandhi
The health ministry said more than 5.58 crore balance and unutilised COVID-19 vaccine doses are still available with the states and UTs to be administered
ZyCoV-D was approved by the country’s apex drug regulator, Drug Controller General of India (DCGI), on August 20. The first indigenously-developed vaccine in India is Bharat Biotech’s Covaxin.
Zydus Cadila's COVID-19 vaccine okayed in India: From interval between doses to efficacy, here's what you must know
The Zydus Cadila vaccine, world's first to use the DNA technology against Sars-Cov-2, is 66 percent effective and expected to hit the market late September or early October
Zydus Cadila vaccine gets EUA for adolescents: A look at scientific, ethical concerns in inoculating minors for COVID-19
Nations like the US, the UK, France, have already begun vaccinating their adolescent population, while Israel, Chile and Malta have achieved one of the highest COVID-19 vaccination rates in the world
These vaccines work by inserting a piece of the virus's genetic information into the body to prompt cells to produce a key component of the virus which the immune system then recognises and attacks by producing antibodies
Zydus Cadila's vaccine may be available for children soon, trials nearly complete, Centre informs Delhi HC
The court observed that it would be a 'disaster' if COVID-19 vaccines are administered to children without conducting proper research
Zydus Cadila plans to roll out COVID vaccine 45-60 days after EUA nod; key points on needle-free, plasmid DNA shot
Dr Sharvil Patel, managing director, Cadila Healthcare, ZyCov-D when approved will help not only adults but also adolescents in the 12 to 18 years age group
Moderna vaccine: The Moderna jab was the second vaccine to get an emergency nod in the US after the Pfizer vaccine, another mRNA shot
India administered 64.25 lakh vaccine doses in a day, taking the cumulative number of jabs given so far under the nationwide inoculation drive to 32.17 crore, according to immunisation data published at 7 am
In affidavit filed in SC, Centre lays out plan to vaccinate adult population against COVID-19 by year-end
The Centre said 51.6 crore doses will be made available for administration by 31 July and submitted the projected availability of vaccines for different sources from August to December for 135 crore doses